Yukihiro Watanabe

ORCID: 0000-0003-0382-8703
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Heart Failure Treatment and Management
  • Cardiovascular Syncope and Autonomic Disorders
  • Cardiovascular Function and Risk Factors
  • Dialysis and Renal Disease Management
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Blood Pressure and Hypertension Studies
  • Cardiac Imaging and Diagnostics
  • Acute Kidney Injury Research
  • COVID-19 and healthcare impacts
  • Galectins and Cancer Biology
  • Protein Tyrosine Phosphatases
  • Cardiac, Anesthesia and Surgical Outcomes
  • Pharmaceutical Practices and Patient Outcomes
  • Blood transfusion and management
  • Hemoglobinopathies and Related Disorders
  • Erythropoietin and Anemia Treatment
  • Vascular anomalies and interventions
  • Acute Myocardial Infarction Research
  • Venous Thromboembolism Diagnosis and Management
  • Connective tissue disorders research
  • Electrolyte and hormonal disorders
  • Parathyroid Disorders and Treatments
  • Healthcare cost, quality, practices
  • Hemodynamic Monitoring and Therapy
  • Sarcoidosis and Beryllium Toxicity Research

Nippon Medical School
2021-2025

Tokyo Health Care University
2023

Nippon Medical School Hospital
2021

Objective The coronavirus disease 2019 (COVID-19) pandemic has had a significant impact on global healthcare systems. Some studies have reported the negative of COVID-19 ST-elevation myocardial infarction (STEMI) patients; however, in Japan remains unclear. This study investigated STEMI patients admitted to an academic tertiary-care center Tokyo, Japan. Methods In this retrospective, observational, cohort study, we included 398 consecutive who were our institute from January 1, 2018, March...

10.2169/internalmedicine.8220-21 article EN Internal Medicine 2021-09-24

Abstract Aims Fractional excretion of urea nitrogen (FEUN), used to differentiate the cause acute kidney injury, has emerged as a useful fluid index in patients with heart failure (HF). We hypothesized that FEUN could be identifying worsening renal function (WRF) associated poor outcomes HF (AHF). Methods and results Overall, 1103 AHF (median age, 78 years; male proportion, 60%) were categorized into six groups according presence WRF values (low, ≤32.1%; medium, >32.1% ≤38.0%; high,...

10.1002/ehf2.14755 article EN cc-by-nc ESC Heart Failure 2024-03-24

Abstract Aims Maintenance of euvolaemia with diuretics is critical in heart failure (HF) patients chronic kidney disease (CKD); however, it challenging because no reliable marker volume status exists. Fractional excretion urea nitrogen (FEUN) a useful index renal failure. We aimed to examine whether FEUN surrogate for risk stratification HF CKD. Methods and results examined 516 CKD (defined as discharge estimated glomerular filtration rate < 60 mL/min/1.73 m 2 ) whose was measured at...

10.1002/ehf2.14327 article EN cc-by-nc-nd ESC Heart Failure 2023-02-23

Red blood cell (RBC) transfusion therapy is often performed in patients with acute heart failure (AHF) and anemia; however, its impact on subsequent cardiovascular events unclear. We examined whether RBC influences major adverse (MACE) after discharge AHF anemia.

10.1536/ihj.23-596 article EN International Heart Journal 2024-03-29

Abstract Background Guideline-directed medical therapy (GDMT) is important in heart failure management; however, polypharmacy itself may impact failure. Although measures against are needed, current discussion on unilateral drug tapering (including the drugs that should be tapered) insufficient. In this study, we investigated relationship between number of prescribed GDMT and prognosis patients with Methods single-centre retrospective 3,146 eligible were included divided into four groups...

10.1186/s40780-024-00357-7 article EN cc-by Journal of Pharmaceutical Health Care and Sciences 2024-07-02

Vascular Ehlers–Danlos syndrome (vEDS) causes fatal vascular complications due to fragility. However, invasive therapeutic procedures are generally avoided except in emergencies. We report a case of vEDS presenting with rapid expansion hepatic arterial aneurysm successfully treated using prophylactic endovascular therapy. A 43-year-old woman confirmed by genetic testing was hospitalized for symptomatic that expanded rapidly within week. Prophylactic coil embolization then performed. Although...

10.3400/avd.cr.20-00144 article EN cc-by-nc-sa Annals of Vascular Diseases 2021-04-29

Background: The Kumamoto criteria have been proposed as a non-invasive screen for transthyretin amyloid cardiomyopathy. This study assessed the validity of externally. Methods and Results: included 138 patients (median age 73 years; 65% male) who underwent 99 mTc-pyrophosphate (PYP) scintigraphy. Patients were divided into 4 groups according to total scores on (i.e., 0-3) following 3 factors: high-sensitivity cardiac troponin T ≥0.0308 ng/mL, wide (≥120 ms) QRS, left ventricular posterior...

10.1253/circrep.cr-22-0110 article EN Circulation Reports 2022-11-25

An 81-year-old woman was referred to our hospital due a cardiac arrest caused by pulmonary embolism (PE) during her hospitalization for bowel obstruction at another hospital.On admission, the patient haemodynamically unstable with return of spontaneous circulation.The treated veno-arterial

10.1093/ehjcr/ytac088 article EN cc-by-nc European Heart Journal - Case Reports 2022-02-01
Coming Soon ...